The First Confirmed Elimination of an Onchocerciasis Focus in Africa: Abu Hamed, Sudan

Am J Trop Med Hyg. 2016 Nov 2;95(5):1037-1040. doi: 10.4269/ajtmh.16-0274. Epub 2016 Jun 27.

Abstract

Mass treatment with ivermectin for onchocerciasis was stopped in 2012 in Abu Hamed, an isolated focus on the River Nile in northern Sudan. A 3-year posttreatment surveillance (PTS) ensued, at the end of which an evaluation was conducted in 2015 following the current World Health Organization guidelines for verification of onchocerciasis elimination. Vector black flies were collected from sentinel breeding sites and finger-prick bloodspots were collected from children ≤ 10 years of age resident in 35 communities within the focus. Polymerase chain reaction (PCR) screening of 19,191 flies from four sites for the O-150 parasite-specific marker found no flies carrying Onchocerca volvulus larvae (0%, 95% upper confidence limit [UCL] = 0.16), and serological testing of 5,266 children identified only one Ov16 seropositive child (0.019%, 95% UCL = 0.074); whose skin snips were negative when tested by O-150 PCR assay. These results indicate that for the first time in Africa, onchocerciasis elimination has been verified after a successful PTS in Abu Hamed.

MeSH terms

  • Animals
  • Carrier Proteins / blood
  • Carrier Proteins / genetics
  • Child
  • Communicable Disease Control*
  • DNA, Helminth / isolation & purification
  • Helminth Proteins / blood
  • Helminth Proteins / genetics
  • Humans
  • Immunoglobulin G / blood
  • Insect Vectors / parasitology
  • Ivermectin / therapeutic use
  • Onchocerca volvulus / isolation & purification
  • Onchocerciasis / drug therapy
  • Onchocerciasis / epidemiology*
  • Onchocerciasis / prevention & control*
  • Polymerase Chain Reaction
  • Simuliidae / parasitology
  • Sudan / epidemiology

Substances

  • Carrier Proteins
  • DNA, Helminth
  • Helminth Proteins
  • Immunoglobulin G
  • Ovd protein, Onchocerca volvulus
  • Ivermectin